Atrial septostomy in severe pulmonary hypertension - more than just a bridge to heart lung transplantation

D. K. Satchithananda, J. Pepke-Zaba, N. Doughty, L. M. Shapiro, K. McNeil (Cambridge, United Kingdom)

Source: Annual Congress 2001 - Disease of the pulmonary circulation
Session: Disease of the pulmonary circulation
Session type: Oral Presentation
Number: 3513
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Abstract

INTRODUCTION: Severe pulmonary hypertension is a progressive condition leading to right ventricular failure and death. Atrial septostomy allows decompression of a failing right ventricle with augmentation of systemic blood flow and an increase in the cardiac index (Sandoval et al J Am Coll Cardiol 1998;32:297-304). METHODS: We evaluated the results of atrial septostomy performed in 13 patients at our center. There were 9 female and 4 male patients (mean age 40, 10 had primary and 3 had secondary pulmonary hypertension). 12 patients had deteriorated despite long-term intravenous prostacyclin therapy (6 had arterial satn of <90% on room air). Standard trans-septal puncture techniques allowed positioning of a Cordis Opta balloon across the inter-atrial septum. Graded balloon dilatations (up to 12mm) were performed until systemic oxygen saturation had decreased by 5-10% and cardiac index had improved. RESULTS: Figures represented as mean (SD).(**=p <0.001)

Cardiac index (l/min/m2)VO2 Sat %O2 Sat %
Pre-septostomy1.66 (0.34)60 (5.5)93.5 (3.1)
Post-septostomy2.07 (0.49) **50.2 (5.5)87.7 (4.4) **


Improvement was seen in 11 patients (reduction in oxygen requirement, ascites, oedema, syncope). Improved cardiac index allowed bridging to heart lung transplantation in 5 (mean 3.4 months post-septostomy) and the institution of dialysis in 2 patients. In our cohort 3 patients died at: <24 hrs (unsuccessful septostomy), 5 (arrhythmia) and 7 (self withdrawal from all medical therapy) days post-septostomy respectively. 5 patients continue to survive on medical management alone (mean 4.2 months post-procedure). CONCLUSIONS: Atrial septostomy provides symptom relief and allows bridging to other supportive or more definitive therapies in patients with severe pulmonary hypertension.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. K. Satchithananda, J. Pepke-Zaba, N. Doughty, L. M. Shapiro, K. McNeil (Cambridge, United Kingdom). Atrial septostomy in severe pulmonary hypertension - more than just a bridge to heart lung transplantation. Eur Respir J 2001; 16: Suppl. 31, 3513

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 1343-1348
Year: 2011



Medical treatment of pulmonary arterial hypertension
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=31
Year: 2003

Right heart failure in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension
Source: Eur Respir Rev 2010 19: 300-307
Year: 2010



Surgical treatment of pulmonary hypertension: thromboendarterectomy, atrial septostomy & transplantation
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012

Pulmonary veno-occlusive disease as a consequence of catheter ablation of atrial fibrillation
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001

Atrial arrhythmias in pulmonary hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


Double-lung transplantation followed by delayed percutaneous repair for atrial septal defect-associated pulmonary arterial hypertension
Source: Eur Respir J, 59 (1) 2102388; 10.1183/13993003.02388-2021
Year: 2022



Right heart imaging and failure in pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Pulmonary hypertension by right heart catheterization in patients with interstitial lung diease
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017


Cardiovascular diseases: congenital, cardiogenic pulmonary oedema, mitral stenosis, chronic heart failure and myocardial infarction
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=290
Year: 2005

Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Long-term survival in pulmonary hypertension with atrial septostomy: a single center experience
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020


Assessment of pulmonary hypertension in lung transplantation candidates; correlation of doppler echocardiography with right heart catheterization
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Prolonged overcirculation-induced pulmonary arterial hypertension, as a cause of right ventricular failure
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011


Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006

Right ventricular function changes after therapy in chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Left atrial volume to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to left heart disease
Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Year: 2011